DETECTION OF SUBCLINICAL MYCOBACTERIUM-AVIUM-INTRACELLULARE COMPLEX INFECTION IN IMMUNODEFICIENT HIV-INFECTED PATIENTS TREATED WITH ZIDOVUDINE

被引:23
作者
MALLAL, SA
JAMES, IR
FRENCH, MAH
机构
[1] ROYAL PERTH HOSP,DEPT CLIN IMMUNOL,PERTH,WA 6001,AUSTRALIA
[2] MURDOCH UNIV,MATH PROGRAMME,MURDOCH,WA,AUSTRALIA
[3] SIR CHARLES GAIRDINER HOSP,DEPT CLIN IMMUNOL,PERTH,WA,AUSTRALIA
[4] UNIV WESTERN AUSTRALIA,DEPT CLIN IMMUNOL,PERTH,WA,AUSTRALIA
关键词
MYCOBACTERIUM AVIUM INTRACELLULARE COMPLEX INFECTION; DELAYED-TYPE HYPERSENSITIVITY; ZIDOVUDINE;
D O I
10.1097/00002030-199409000-00007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To test the hypothesis that subclinical Mycobacterium avium intracellulare complex (MAC) infection may result in the development of a tuberculin response in immunodeficient HIV-infected individuals treated with zidovudine. Design: Longitudinal, observational study. Setting: The Western Australian HIV Cohort Study; a prospective, single centre, population-based observational study of the natural history of HIV disease. Patients: Forty-nine patients with impaired delayed-type hypersensitivity (DTH) responses and negative tuberculin responses in whom DTH responses were augmented within 6 months of starting zidovudine therapy. Outcome measures: Progression to disseminated MAC infection stratified according to the presence or absence of a tuberculin response in the first 6 months of zidovudine therapy. Results: Twenty-nine of the patients developed a post-zidovudine tuberculin response. None of the tuberculin non-responders developed disseminated MAC infection during the study period; the Kaplan-Meier probability estimate of disseminated MAC infection was 50% at 24 months and reached 100% 40 months after zidovudine was commenced in tuberculin responders. All patients with disseminated MAC infection had become anergic to all antigens, including tuberculin, before diagnosis. The probability of a post-zidovudine tuberculin response was related to the severity of peripheral blood CD4+ T-cell depletion, rising from an estimated 20% at 20% CD4+ T cells to 100% at less than or equal to 1% CD4+ T cells. Conclusions: The restoration of a cellular immune response against subclinical MAC infection can be demonstrated by measuring the DTH response to tuberculin in patients with impaired DTH augmented by zidovudine therapy. The findings suggest that MAC infection is almost inevitable, but often asymptomatic, in profoundly immunodeficient HIV-infected patients and that a prolonged subclinical phase of MAC infection is usual.
引用
收藏
页码:1263 / 1269
页数:7
相关论文
共 20 条
[1]  
CHAPARAS SD, 1984, MYCOBACTERIA SOURCEB
[2]  
CHEAH D, 1992, COMM DIS INTELL, V16, P398
[3]   A T(H)1-]T(H)2 SWITCH IS A CRITICAL STEP IN THE ETIOLOGY OF HIV-INFECTION [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1993, 14 (03) :107-110
[5]   CORRECTION OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED DEPRESSION OF DELAYED-TYPE HYPERSENSITIVITY (DTH) AFTER ZIDOVUDINE THERAPY - DTH, CD4+ T-CELL NUMBERS, AND EPIDERMAL LANGERHANS CELL-DENSITY ARE INDEPENDENT VARIABLES [J].
FRENCH, MAH ;
CAMERON, PU ;
GRIMSLEY, G ;
SMYTH, LA ;
DAWKINS, RL .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 55 (01) :86-96
[6]   ZIDOVUDINE-INDUCED RESTORATION OF CELL-MEDIATED-IMMUNITY TO MYCOBACTERIA IN IMMUNODEFICIENT HIV-INFECTED PATIENTS [J].
FRENCH, MAH ;
MALLAL, SA ;
DAWKINS, RL .
AIDS, 1992, 6 (11) :1293-1297
[7]   COMPARISON OF DELAYED-TYPE HYPERSENSITIVITY AND T-SUBSETS IN RANDOM AND HOMOSEXUAL POPULATIONS IN WESTERN AUSTRALIA [J].
GRIMSLEY, G ;
LATTIMORE, M ;
DAWKINS, RL .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1984, 14 (02) :115-120
[8]   DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION - CLINICAL-IDENTIFICATION AND EPIDEMIOLOGIC TRENDS [J].
HAVLIK, JA ;
HORSBURGH, CR ;
METCHOCK, B ;
WILLIAMS, PP ;
FANN, SA ;
THOMPSON, SE .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) :577-580
[9]   MYCOBACTERIUM-AVIUM COMPLEX INFECTIONS IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
HAWKINS, CC ;
GOLD, JWM ;
WHIMBEY, E ;
KIEHN, TE ;
BRANNON, P ;
CAMMARATA, R ;
BROWN, AE ;
ARMSTRONG, D .
ANNALS OF INTERNAL MEDICINE, 1986, 105 (02) :184-188
[10]   SURVIVAL OF PATIENTS WITH ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME AND DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION WITH AND WITHOUT ANTIMYCOBACTERIAL CHEMOTHERAPY [J].
HORSBURGH, CR ;
HAVLIK, JA ;
ELLIS, DA ;
KENNEDY, E ;
FANN, SA ;
DUBOIS, RE ;
THOMPSON, SE .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (03) :557-559